Jonathan Canaani, M.D.


Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • HMO
  • Medicare
  • PPO
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

I am a hematologist/oncologist who takes care of people with blood cancers with a specific focus on caring for those with leukemia. I strive to provide patients with the best medical care possible while prioritizing direct and open communication with both my patients as well as their supporting families. The field of hematologic malignancies is witnessing unprecedented advances in diagnostics and therapeutics, resulting in substantial gains in life expectancy and quality of life for our patients and I feel fortunate and grateful to be treating patients with blood cancers at Weill Cornell Medicine. 

Biographical Info

Dr. Jonathan Canaani is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine and the director of the Hematologic Malignancies Program at NewYork-Presbyterian Brooklyn Methodist Hospital. Dr. Canaani received his B.S. with honors from the University of Tel-Aviv, Israel in 2003, and his M.D. from the Tel-Aviv University School of Medicine in 2009. He trained in Internal Medicine at the Tel-Aviv Medical Center. During residency, Dr. Canaani also completed a research fellowship at the Weizmann Institute of Science focusing on the molecular biology of hematopoietic stem cells. He continued his medical training at the Hospital of the University of Pennsylvania, completing a fellowship in Hematology and Medical Oncology in 2013. During his fellowship at Penn, Dr. Canaani focused his clinical efforts within the field of leukemia and became involved in studying response patterns to novel FLT3 inhibitors in acute myeloid leukemia patients. During fellowship, Dr. Canaani was awarded the American Society of Hematology (ASH) Research Training Award for Fellows (ASH RTAF). In 2016, Dr. Canaani relocated to Israel to serve as Director of the Adult Leukemia Program at the Sheba Medical Center where he also held the title of Senior Lecturer of Hematology at the University of Tel-Aviv. His main area of research has been focused on conducting translational research in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), which aims to delineate molecular correlates that are associated with specific response patterns in leukemia patients receiving conventional chemotherapies and  novel targeted therapies. In collaboration with the European Society for Blood and Marrow Transplantation (EBMT), Dr. Canaani made several important contributions to clinical research outlining the clinical outcomes of AML and ALL patients undergoing allogeneic stem cell transplantation. With the recent introduction of novel immune and signaling transduction-based therapeutic platforms into the routine care of leukemia patients, Dr. Canaani's current research efforts endeavor to integrate precision oncology approaches to evaluate real-world outcomes of designated patient subsets and to improve cancer care delivery.

Clinical Expertise
ALL (Acute Lymphoblastic Leukemia)
AML (Acute Myeloblastic Leukemia)
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Myeloid Leukemia
Myelodysplastic Syndromes
Myeloproliferative Neoplasms
  • M.D.
    Sackler School of Medicine, Tel Aviv University (Israel)
  • B.Sc.
    Tel Aviv University (Israel)
  • Associate Attending Physician
    NewYork-Presbyterian Hospital
  • Associate Attending Physician
    NewYork-Presbyterian/Brooklyn Methodist Hospital
  • Associate Professor of Medicine (Pending Appointment at Rank)
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

No External Relationships Reported